Biovance Capital

Biotech-focused venture capital firm.

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
	Laigo Bio	$6.0M Laigo Bio Seed Extension Mar 2026	Kurma Partners, Biovance Capital, Joao Incio, MD PhD	Angelini Ventures, ArgoBio, Cancer Research Horizons, Curie Capital, Eurazeo, Oncode Oncology Bridge Fund, ROM Utrecht Region